STOCK TITAN

Preferred conversions lift Corvex (NASDAQ: MOVE) to 27,635,745 shares

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Corvex, Inc. reports several governance and capital-structure changes tied to its merger with Corvex Legacy Holdings. The board appointed Seth Demsey as co-Chief Executive Officer alongside Jay Crystal, consistent with the merger agreement and his prior role leading Corvex OpCo.

Stockholders approved the 2026 Equity Incentive Plan and a new 2026 Employee Stock Purchase Plan, as well as Nasdaq Listing Rule 5635 proposals permitting issuance of more than 20% of common stock upon conversion of Series C and Series D preferred shares and upon vesting of pre-merger equity awards.

The company increased authorized Series D Preferred Stock to 50,000 shares to support a preferred exchange. After stockholder approval, on July 7, 2026 all Series C Preferred Stock converted into common shares, and Series D Preferred Stock conversions representing 4,752,244 common shares were completed. Following these conversions, Corvex has 27,635,745 common shares outstanding, with remaining Series D Preferred Stock convertible into 28,929,592 additional common shares.

Positive

  • None.

Negative

  • Stockholders approved issuances exceeding 20% of outstanding common stock for preferred, RSU, and option conversions, and the company completed preferred conversions that lifted common shares outstanding to 27,635,745 with a further 28,929,592 shares still issuable from Series D, materially expanding equity overhang.

Insights

Corvex unlocks large preferred conversions, expanding its common share base.

Corvex’s actions consolidate its post-merger capital structure. Stockholders approved key Nasdaq 5635 proposals allowing issuance of more than 20% of existing common shares for preferred conversions and legacy equity awards, and authorized more Series D Preferred Stock to facilitate exchanges.

The July 7, 2026 conversions of all Series C Preferred Stock plus Series D representing 4,752,244 common shares raised total common shares outstanding to 27,635,745, while Series D remains convertible into 28,929,592 additional shares. This creates substantial potential future issuance tied to remaining preferred conversions.

Governance-wise, appointing co-CEO Seth Demsey aligns management with the acquired Corvex OpCo platform. Future filings describing further preferred conversions or exercises under the new 2026 equity and ESPP plans will show how quickly the authorized overhang turns into issued common stock.

Item 3.02 Unregistered Sales of Equity Securities Securities
The company sold equity securities in a private placement or other unregistered transaction.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Governance
The company amended its charter documents, bylaws, or changed its fiscal year.
Item 5.07 Submission of Matters to a Vote of Security Holders Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Authorized Series D Preferred 50,000 shares Authorized shares after Certificate of Increase
Series D converted 4,752,244 shares Common shares underlying Series D conversion on July 7, 2026
Common shares outstanding 27,635,745 shares Outstanding after preferred conversions on July 7, 2026
Remaining Series D convertible 28,929,592 shares Additional common shares issuable from Series D Preferred Stock
Conversion Proposal approval votes 605,849 For; 1,326 Against; 1,024 Abstain Nasdaq 5635 preferred conversion proposal
2026 Plan approval votes 731,164 For; 23,323 Against; 1,777 Abstain Corvex 2026 Equity Incentive Plan
ESPP approval votes 745,067 For; 9,567 Against; 1,630 Abstain 2026 Employee Stock Purchase Plan
Series D Non-Voting Convertible Preferred Stock financial
"the Company issued shares of Series C Non-Voting Convertible Preferred Stock ... and Series D Non-Voting Convertible Preferred Stock"
Conversion Proposal financial
"the issuance of more than 20% of the Company’s issued and outstanding common stock in connection with the conversion ... (the “Conversion Proposal”)"
2026 Equity Incentive Plan financial
"the stockholders of the Company approved the Corvex, Inc. 2026 Equity Incentive Plan (the “2026 Plan”)"
2026 Employee Stock Purchase Plan financial
"the Company’s stockholders approved the Corvex, Inc. 2026 Employee Stock Purchase Plan (the “ESPP”)"
Nasdaq Listing Rule 5635(a) and 5635(b) regulatory
"for purposes of complying with Nasdaq Listing Rule 5635(a) and 5635(b), the issuance of more than 20% of the Company’s issued and outstanding common stock"
Certificate of Increase regulatory
"the Company filed a Certificate of Increase with the Secretary of State of the State of Delaware to increase the number of authorized shares of Series D Preferred Stock"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What leadership change did Corvex (MOVE) announce in this 8-K?

Corvex appointed Seth Demsey as co-Chief Executive Officer alongside Jay Crystal. Demsey had been Co-CEO and Co-Founder of Corvex OpCo and a Corvex director since March 2026, bringing deep AI, cloud infrastructure, and distributed computing experience to the company’s top leadership team.

What equity plans did Corvex (MOVE) stockholders approve?

Stockholders approved the Corvex, Inc. 2026 Equity Incentive Plan and the 2026 Employee Stock Purchase Plan. Both plans were described in the 2026 Annual Meeting proxy statement and are intended to govern future stock-based awards and employee share purchases under newly adopted programs.

How did preferred stock conversions affect Corvex (MOVE) common shares?

After stockholder approval, all Series C Preferred Stock automatically converted into common shares, and Series D Preferred Stock conversions representing 4,752,244 common shares were completed. Following these actions, Corvex reported 27,635,745 common shares outstanding as of July 7, 2026.

How much Series D Preferred Stock remains convertible at Corvex (MOVE)?

Following the July 7, 2026 conversions, Corvex reported outstanding Series D Preferred Stock still convertible into 28,929,592 shares of common stock. Earlier, the company increased authorized Series D Preferred Stock to 50,000 shares via a Certificate of Increase filed in Delaware.

What Nasdaq Listing Rule approvals did Corvex (MOVE) obtain?

Stockholders approved proposals under Nasdaq Listing Rules 5635(a) and 5635(b) to permit issuing more than 20% of Corvex’s outstanding common stock for conversions of Series C and Series D preferred shares and for vesting or exercise of pre-merger restricted stock units and options.

What audit firm did Corvex (MOVE) stockholders ratify for 2026?

Corvex stockholders ratified BDO USA, P.C. as the independent registered public accounting firm for 2026. The vote received 1,418,132 shares cast “For,” 1,131 “Against,” and 1,332 “Abstain,” with no broker non-votes reported for this auditor ratification item.
false --12-31 0001734750 0001734750 2026-07-01 2026-07-01 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): July 1, 2026

 

CORVEX, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-40254   82-4233771
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (I.R.S. Employer
Identification No.)

 

3401 North Fairfax Drive, Suite 3230,

ArlingtonVirginia

  22226
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (866) GET-GPUS ((866438-4787)

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, $0.0001 par value per share   MOVE  

The Nasdaq Stock Market LLC

 

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

  

 

 

 

 

 

Item 3. 02 Unregistered Sales of Equity Securities.

 

The disclosure under Item 8.01 below is incorporated by reference into this Item 3.02.

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

As previously disclosed, on March 19, 2026, Corvex, Inc. (the “Company”) acquired Corvex Legacy Holdings, Inc. (formerly known as Corvex, Inc.) (“Corvex OpCo”), in accordance with the terms of the Amended and Restated Agreement and Plan of Merger, dated March 19, 2026 (the “Merger Agreement”), by and among the Company, Thor Merger Sub Inc., a Delaware corporation and a wholly-owned subsidiary of the Company (“Merger Sub”), and Corvex OpCo. Pursuant to the Merger Agreement, Merger Sub merged with and into Corvex OpCo, pursuant to which Corvex OpCo was the surviving corporation and became a wholly owned subsidiary of the Company (the “Merger”). 

 

Appointment of Seth Demsey as co-Chief Executive Officer

 

On July 1, 2026, as previously disclosed and pursuant to the terms of the Merger Agreement, Seth Demsey was appointed co-Chief Executive Officer of the Company, alongside Jay Crystal, effective following the Annual Meeting (as defined below). 

 

Mr. Demsey, age 49, has served as a member of the Company’s board of directors since March 19, 2026. Mr. Demsey has served as the Co-Chief Executive Officer and Co-Founder of Corvex OpCo and on the Corvex OpCo board of directors since October 2024. Before joining Corvex OpCo, Mr. Demsey served as the chief executive officer and co-founder of Configure8 from May 2021 through October 2024. He has spent nearly three decades architecting and operating high-impact AI/ML and developer platforms across startups and industry leaders including NASA, Microsoft, Google, and AOL/Yahoo!. He holds dozens of patents spanning high-performance computing, distributed systems, security, and data management. Prior to co-founding Corvex OpCo, Mr. Demsey served in technical leadership roles driving innovation in large-scale distributed computing and mission-critical infrastructure. His expertise encompasses the full stack of cloud infrastructure technologies required to deliver reliable, high-performance AI computing at scale. Mr. Demsey received a Bachelor of Science degree in Computer Engineering from Bucknell University and was previously a business fellow at The Wharton School of the University of Pennsylvania. 

 

Pursuant to the Merger Agreement, on March 19, 2026, the Company entered into an Employment Agreement with Mr. Demsey. A description of the terms and conditions of Mr. Demsey’s Employment Agreement is set forth in Item 5.02 of the Company’s Current Report on Form 8-K, as filed with the Securities and Exchange Commission on March 19, 2026 (the “March 19 Form 8-K”), which such description is incorporated by reference herein. Such description of Mr. Demsey’s Employment Agreement does not purport to be complete and is qualified in its entirety by reference to Mr. Demsey’s Employment Agreement, a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.

 

1

 

 

Approval of Corvex, Inc. 2026 Equity Incentive Plan

 

On July 1, 2026, the stockholders of the Company approved the Corvex, Inc. 2026 Equity Incentive Plan (the “2026 Plan”).  A description of the terms and conditions of the 2026 Plan is set forth in the Company’s Proxy Statement for the 2026 Annual Meeting of Stockholders of the Company that was commenced on June 26, 2026, adjourned, and reconvened on July 1, 2026 (the “Annual Meeting”), as filed with the Securities and Exchange Commission on June 5, 2026 (the “Annual Meeting Proxy Statement”) under the heading “Proposal 5 – The 2026 Plan Proposal”, which such description is incorporated by reference herein.  This summary does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the 2026 Plan, a copy of which is filed as Exhibit 10.2 to this Current Report on Form 8-K and is incorporated herein by reference.

 

Approval of Corvex, Inc. 2026 Employee Stock Purchase Plan

 

On July 1, 2026, the Company’s stockholders approved the Corvex, Inc. 2026 Employee Stock Purchase Plan (the “ESPP”) at the Annual Meeting. A description of the terms and conditions of the ESPP is set forth in the Annual Meeting Proxy Statement under the heading “Proposal 6 – The 2026 ESPP Proposal”, which such description is incorporated by reference herein. This summary does not purport to be complete and is subject to, and qualified in its entirety, by the full text of the ESPP, a copy of which is filed as Exhibit 10.3 to this Current Report on Form 8-K and is incorporated herein by reference.

 

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

 

Amendment to Series D Preferred Stock

 

As previously disclosed, in connection with the Merger the Company issued shares of Series C Non-Voting Convertible Preferred Stock, par value $0.0001 per share (the “Series C Preferred Stock”) and Series D Non-Voting Convertible Preferred Stock, par value $0.0001 per share (the “Series D Preferred Stock”) to the former security holders of Corvex OpCo. Certain holders of Series C Preferred Stock (the “Exchanging Stockholders”) expressed interest in exchanging their shares of Series C Preferred Stock for Series D Preferred Stock before the Annual Meeting. On July 1, 2026, the Company entered into exchange agreements with the Exchanging Stockholders to accommodate these requests (the “Preferred Exchange”). 

 

In connection with the Preferred Exchange, the Company filed a Certificate of Increase with the Secretary of State of the State of Delaware to increase the number of authorized shares of Series D Preferred Stock to 50,000 shares (the “Certificate of Increase”). The Certificate of Increase did not otherwise amend the Certificate of Designations for the Series D Preferred Stock.

 

The foregoing description of the Certificate of Increase does not purport to be complete and is qualified in its entirety by reference to the Certificate of Increase, a copy of which is filed as Exhibit 3.1 to this Current Report on Form 8-K and is incorporated herein by reference.

 

2

 

 

Item 5.07 Submission of Matters to a Vote of Security Holders.

 

On July 1, 2026, the Company reconvened the Annual Meeting that was commenced on June 26, 2026 and adjourned until July 1, 2026. The certified results of each of the matters voted upon at the Annual Meeting, which are more fully described in the Annual Meeting Proxy Statement, follow.

 

The Company’s stockholders elected two nominees to the Company’s Board of Directors (the “Board”) to serve for three-year terms as Class II directors and one nominee to the Board to serve for a one-year term as a Class III director, with votes cast as follows:

 

Director Name  For   Withheld   Broker
Non-Votes
 
Jay Crystal, Class II Director   756,080    184    664,331 
Patrick Fleury, Class II Director   756,080    184    664,331 
Nicholas Donofrio, Class III Director   752,073    4,191    664,331 

 

The Company’s stockholders approved, for purposes of complying with Nasdaq Listing Rule 5635(a) and 5635(b), the issuance of more than 20% of the Company’s issued and outstanding common stock in connection with the conversion of shares of Series C Preferred Stock and Series D Preferred Stock pursuant to the Merger Agreement (the “Conversion Proposal”), with votes cast as follows:

 

For  Against   Abstain   Broker Non-Votes 
605,849   1,326    1,024    664,331 

 

 

The Company’s stockholders approved, for purposes of complying with Nasdaq Listing Rule 5635(a) and 5635(b), the issuance of more than 20% of the Company’s issued and outstanding common stock in connection with the vesting of restricted stock units and exercise of options issued and outstanding prior to the Merger pursuant to the Merger Agreement, with votes cast as follows:

 

For  Against   Abstain   Broker Non-Votes 
605,237   1,803    1,159    664,331 

 

The Company’s stockholders ratified the appointment of BDO USA, P.C. as the Company’s independent registered public accounting firm for 2026, with votes cast as follows:

 

 For  Against   Abstain   Broker Non-Votes 
1,418,132   1,131    1,332    -- 

 

The Company’s stockholders approved the 2026 Plan and the awards described in the New Plan Benefits table, the issuance of which are subject to the approval of the 2026 Plan, with votes cast as follows:

 

For  Against   Abstain   Broker Non-Votes 
731,164   23,323    1,777    664,331 

 

The Company’s stockholders approved the ESPP, with votes cast as follows:

 

For  Against   Abstain   Broker Non-Votes 
745,067   9,567    1,630    664,331 

 

 The Company’s stockholders approved the adjournment of the Annual Meeting to permit further solicitation of proxies, if necessary or appropriate, with votes cast as follows:

 For  Against   Abstain   Broker Non-Votes 
1,416,097   2,113    2,385    664,331 

 

3

 

 

Item 8.01 Other Events.

 

Following the Annual Meeting and stockholder approval of the Conversion Proposal, on July 7, 2026, all outstanding shares of Series C Preferred Stock automatically converted into shares of the Company’s common stock in accordance with the Certificate of Designations for the Series C Preferred Stock. Additionally, on July 7, 2026, the Company effected the conversion shares of Series D Preferred Stock representing 4,752,244 shares of common stock into common stock pursuant to conversion notices submitted by holders of Series D Preferred Stock. Following such conversions, the Company has 27,635,745 shares of common stock outstanding and shares of Series D Preferred Stock convertible into 28,929,592 shares of common stock.

 

Item 9.01 Financial Statements and Exhibits.

 

Exhibits

 

The following exhibits are filed herewith:

 

Exhibit No.   Exhibit Description
     
3.1   Certificate of Increase of Series D Non-Voting Convertible Preferred Stock
10.1   Employment Agreement between the Company and Seth Demsey (previously filed as Exhibit 10.5 to the Company’s Current Report on Form 8-k filed on March 19, 2026, which is incorporated herein by reference)
10.2   Corvex, Inc. 2026 Equity Incentive Plan (previously filed as Exhibit 4.12 to the Company’s Form S-8 (File No. 333-297203) filed on July 1, 2026, which is incorporated herein by reference)
10.3   Corvex, Inc. 2026 Employee Stock Purchase Plan (previously filed as Exhibit 4.15 to the Company’s Form S-8 (File No. 333-297203) filed on July 1, 2026, which is incorporated herein by reference)
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

4

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  CORVEX, INC.
     
Date: July 7, 2026 By: /s/ Chance Moreland
    Chance Moreland
    Chief Financial Officer

 

5

Filing Exhibits & Attachments

4 documents